You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vactosertib

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

Not yet recruiting
  • Adenocarcinoma Esophagus
  • +3 more
  • Vactosertib
  • +2 more
  • (no location specified)
Sep 13, 2023

Pancreas Cancer Trial in Seoul (Vactosertib)

Recruiting
  • Pancreas Cancer
  • Vactosertib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Osteosarcoma Trial (Vactosertib)

Not yet recruiting
  • Osteosarcoma
  • Vactosertib
  • (no location specified)
Oct 18, 2022

Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)

Not yet recruiting
  • Acral Melanoma
  • Mucosal Melanoma
  • Pembrolizumab, Vactosertib
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 23, 2022

Desmoid Tumor Trial in Seoul (vactosertib/imatinib combination)

Recruiting
  • Desmoid Tumor
  • vactosertib/imatinib combination
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Jun 14, 2022

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Vactosertib
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Gastric Cancer Trial (Vactosertib)

Not yet recruiting
  • Gastric Cancer
  • Vactosertib
  • (no location specified)
Jun 13, 2022

Myeloproliferative Tumor Trial in New York (Vactosertib)

Recruiting
  • Myeloproliferative Neoplasm
  • Vactosertib
  • New York, New York
    Weill Medical College of Cornell University
Dec 20, 2021

Urothelial Carcinoma Recurrent, Advanced Urothelial Carcinoma Trial in San Francisco, Buffalo (Vactosertib(TEW-7197)/

Not yet recruiting
  • Urothelial Carcinoma Recurrent
  • Advanced Urothelial Carcinoma
  • Vactosertib(TEW-7197)/ Durvalumab
  • San Francisco, California
  • +1 more
Sep 22, 2021

NSCLC Trial in Seoul (Vactosertib 300 mg BID and pembrolizumab 200 mg IV)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Vactosertib 300 mg BID and pembrolizumab 200 mg IV
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 22, 2021

Stomach Tumor Trial (durvalumab and vactosertib)

Not yet recruiting
  • Stomach Neoplasm
  • durvalumab and vactosertib
  • (no location specified)
May 14, 2021

MDS Trial in Tampa, Baltimore, Bronx (TEW-7197)

Completed
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +2 more
Sep 22, 2021

NSCLC Metastatic Trial in Korea, Republic of (TEW-7197)

Active, not recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Chungju, Korea, Republic of
  • +3 more
Mar 17, 2021

Metastatic Gastric Cancer Trial in Anyang-si, Hwasun, Seoul (TEW-7197)

Unknown status
  • Metastatic Gastric Cancer
  • Anyang-si, Korea, Republic of
  • +5 more
Mar 17, 2021

Healthy Volunteers Trial in Busan (TEW-7197)

Completed
  • Healthy Volunteers
  • Busan, Korea, Republic of
    Inje University Busan Paik Hospital
Apr 10, 2020

Advanced Stage Solid Tumors Trial in Durham, Nashville (TEW-7197)

Completed
  • Advanced Stage Solid Tumors
  • Durham, North Carolina
  • +2 more
May 8, 2019